Pharma Stability: Insights, Guidelines, and Expertise
Pharmaceutical stability programs are under constant regulatory scrutiny due to their impact on product shelf life, quality, and patient safety. However, stability testing also remains one of the most frequent areas for GMP non-compliance during inspections by the USFDA, EMA, and WHO. This article outlines the most common GMP deviations observed in stability studies and…
Understanding the Tip: Why batch and environmental records matter in stability data: Stability studies rely on the assumption that samples were manufactured according to GMP and stored under qualified conditions. Cross-verifying batch manufacturing records (BMRs) and chamber logs ensures that the data generated is not only scientifically sound but also compliant with regulatory requirements. Failing…
Read More “Cross-Verify Batch Records and Chamber Logs Before Finalizing Stability Data” »
Understanding the Tip: What qualifies as a deviation: Any fluctuation outside the validated storage conditions—whether temperature, humidity, or light exposure—constitutes a deviation. Even brief or minor excursions can affect product stability, especially for sensitive formulations. Ignoring small changes may compromise the reliability of the data and lead to misleading conclusions about product shelf life. Why…
Read More “Always Record Even Minor Deviations from Storage Conditions in Stability Studies” »